Monte Rosa Therapeutics, Inc. (GLUE) announced the publication of groundbreaking new discoveries. These findings were featured on the cover of Science. The research article details how Monte Rosa Therapeutics has developed a proprietary artificial intelligence and machine learning engine. This engine has uncovered a broad range of human proteins potentially accessible to cereblon-based degradation.
These findings dramatically expand the actionable target space for MGD drug discovery at MGD Pharmaceuticals. This expansion opens new avenues for developing effective treatments.
The stock had closed the regular trading day at $4.87. Earlier in the day, GLUE opened at $4.79, with trading prices ranging between $4.64 and $4.88. The day’s trading volume reached 193.20 thousand shares.
